Opinion
2012-1397 2012-1398 2012-1400 2012-1424
07-02-2012
BAYER HEALTHCARE PHARMACEUTICALS INC. AND BAYER SCHERING PHARMA AG, Plaintiffs-Appellees, WATSON PHARMACEUTICALS, INC. AND WATSON LABORATORIES, INC., Defendants-Appellants, AND SANDOZ INC., Defendant-Appellant. BAYER SCHERING PHARMA AG AND BAYER HEALTHCARE PHARMACEUTICALS, INC., Plaintiffs-Appellees, v. LUPIN, LTD. and LUPIN PHARMACEUTICALS, INC., Defendants-Appellants
NOTE: This order is nonprecedential.
Appeals from the United States District Court for the District of Nevada in consolidated case nos. 07-CV-1472 AND 08-CV-0995, Judge Kent J. Dawson.
Appeal from the United States District Court for the District of Nevada in case no. 10-CV-1166, Judge Kent J. Dawson.
ON MOTION
Before LOURIE, Circuit Judge.
ORDER
Upon consideration of Sandoz Inc., Watson Pharmaceuticals, Inc., Watson Laboratories, Inc., Lupin Ltd., and Lupin Pharmaceuticals, Inc.'s unopposed motion to consolidate appeal 2012-1397 et al. with appeal 2012-1424, and for additional words in the parties' briefs,
It Is Ordered That:
The motion to consolidate the appeals is granted. The appellants' opening brief is due no later than July 16, 2012. The motion to increase the word count for the briefs is denied. The revised official caption is reflected above.
FOR THE COURT
____________________________
Jan Horbaly
Clerk
cc: Peter B. Bensinger, Jr., Esq.
Robert Fritz Green, Esq.
Joseph A. Hynds, Esq.
Mark T. Jansen, Esq.
s26